Brief: VYNE Therapeutics Q3 Adjusted Net Income USD -5.721 Million

YARROW BIOSCIENCE

13/11/2023 12:45

Nov 13 (Reuters) - VYNE Therapeutics Q3 basic EPS USD -2.01.
* Q3 EPS from cont ops USD -1.85
* Q3 net income USD -6.584 million
* Q3 revenue USD 114 thousand